97
Wang Z#, Deng T#, Zhang Y#, Niu W, Nie Q, Yang S, Liu P, Pei P, Chen L, Li H*, Cao B*. ACE2 can act as the secondary receptor in the FcgammaR-dependent ADE of SARS-CoV-2 infection. iScience. 2022 Jan 21;25(1):103720. doi: 10.1016/j.isci.2021.103720. Epub 2021 Dec 31.
98
Cui D#, Chen S#, Feng L#, Jia M#, Wang Y#, Xiao W, Sun Y, Huang Q, Ma L, Leng Z, Wang H, Cao B*, Yang W*, Yang J*, Wang C*.Long-term outcomes in COVID-19 patients who recovered from the first wave of the pandemic.Natl Sci Rev. 2022 Sep 20;9(11):nwac192. doi: 10.1093/nsr/nwac192. eCollection 2022 Nov.
99
Zou X#, Nguyen M, Overbeek J, Cao B*, Davis JJ*.Classification of bacterial plasmid and chromosome derived sequences using machine learning.PLoS One. 2022 Dec 16;17(12):e0279280. doi: 10.1371/journal.pone.0279280. eCollection 2022.
100
Zhang H#, Li X#, Huang L#, Gu X#, Wang Y, Liu M, Liu Z, Zhang X, Yu Z, Wang Y*, Huang C*, Cao B*.Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study.EClinicalMedicine. 2022 Sep 28;54:101668. doi: 10.1016/j.eclinm.2022.101668. eCollection 2022 Dec.
101
Shu Jing Shi , Hui Li , Meng Liu, Ying Mei Liu, Fei Zhou , Bo Liu , Jiu Xin Qu, Bin Cao.Mortality prediction to hospitalized patients with influenza pneumonia: PO2 /FiO2 combined lymphocyte count is the answer. Clin Respir J. 2017 May;11(3):352-360.doi: 10.1111/crj.12346. Epub 2015 Aug 11.
102
Cui D#, Wang Y#, Huang L#, Gu X#, Huang Z, Mu S, Wang C*, Cao B*. Rheumatic Symptoms Following Coronavirus Disease 2019 (COVID-19): A Chronic Post-COVID-19 Condition. Open Forum Infect Dis. 2022 May 23;9(6):ofac170. doi: 10.1093/ofid/ofac170.
103
Han X#, Chen L, Li H, Zhou F, Xing X, Zhang C, Suo L, Wang J, Liu X*, Cao B*, CAP-China network. Prognostic Factors for Cardiovascular Events in Elderly Patients with Community Acquired Pneumonia: Results from the CAP-China Network. Clin Interv Aging. 2022 Apr 23;17:603-614. doi: 10.2147/CIA.S356925.
104
Zhuo X#, Zhao J, Wang L, Sun B, Sun L, Wang C, Li B, Fan Y, Liu Y*, Cao B*. Development and evaluation of a multiplex quantitative polymerase chain reaction assay for detecting bacteria associated with lower respiratory tract infection. Int J Infect Dis. 2022 May 26;122:202-211. doi: 10.1016/j.ijid.2022.05.052.
105
Li H#, Zhao M#, Zhang H, Quan C, Zhang D, Liu Y, Liu M, Xue C, Tan S, Guo Y, Zhao Y, Wu G, Gao GF*, Cao B*, Liu WJ*. Pneumonia Severity and Phase Linked to Virus-Specific T Cell Responses with Distinct Immune Checkpoints during pH1N1 Infection.J Immunol. 2022 May 1;208(9):2154-2162. doi: 10.4049/jimmunol.2101021.
106
Xu J#, Cao B*. Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19. Eur Respir J. 2022 Jan 6;59(1):2102002. doi: 10.1183/13993003.02002-2021.
107
Gu X#, Cao B*. Understanding of COVID-19 from infection-fatality ratio. Lancet. 2022 Apr 16;399(10334):1442-1443. doi: 10.1016/S0140-6736(22)00281-1.
108
Zhang Y#, Zhao J, Han J, Fan Y, Xiong Z, Zou X, Li B, Liu X, Li Z, Lu B*, Cao B*. Synergistic Activity of Imipenem in Combination with Ceftazidime/Avibactam or Avibactam against Non-MBL-Producing Extensively Drug-Resistant Pseudomonas aeruginosa. Microbiol Spectr. 2022 Apr 27;10(2):e0274021. doi: 10.1128/spectrum.02740-21.
109
Huang L#, Gu X, Zhang H, Cao B*. A glimpse into long COVID and symptoms - Authors' reply. Lancet Respir Med. 2022 Jun 10;S2213-2600(22)00212-0. doi: 10.1016/S2213-2600(22)00212-0.
110
Chang K#, Wang H#, Zhao J, Yang X, Wu B, Sun W, Huang M, Cheng Z, Chen H, Song Y, Chen P, Chen X, Gan X, Ma W, Xing L, Wang Y, Gu X, Zou X, Cao B*.Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii. Front Med (Lausanne). 2022 Jun 10;9:772372. doi: 10.3389/fmed.2022.772372.
111
Zhang X#, Shang L#, Fan G, Gu X, Xu J, Wang Y, Huang L, Cao B*. The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis. Front Med (Lausanne).2022 Jan 27;8:800492. doi: 10.3389/fmed.2021.800492.
112
Huang Z#, Li H, Liu S, Jia J, Zheng Y, Cao B*. Identification of Neutrophil-Related Factor LCN2 for Predicting Severity of Patients With Influenza A Virus and SARS-CoV-2 Infection. Front Microbiol. 2022 Apr 12;13:854172. doi: 10.3389/fmicb.2022.854172.
